Order
33048-54-3
6-(3-bromophenyl)-4-hydroxy-4-methyl-2-[2-(morpholin-4-yl)ethyl]-4,5-dihydropyridazin-3(2H)-one hydrochloride (1:1)
Order
330645-26-6
3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-[4-(phenylmethoxy)phenyl]-, diethyl ester
Order
391642-89-0
Butanoic acid,4-[(4-amino-9,10-dihydro-9,10-dioxo-3-sulfo-1-anthracenyl)amino]-4-oxo-
Order
841275-14-7
2-Pyrrolidinecarboxamide,N-[12-[(4-fluoro-3-hydroxybenzoyl)amino]dodecyl]-5-oxo-, (2R)-
Order
500150-54-9
Butanoic acid,4-[(3-methyl-2-butenyl)(2-naphthalenylmethyl)amino]-2,4-dioxo-,1,1-dimethylethyl ester
Order
33048-52-1
4-hydroxy-4-methyl-2-[2-(morpholin-4-yl)ethyl]-6-phenyl-4,5-dihydropyridazin-3(2H)-one hydrochloride (1:1)
330645-26-6,33048-52-1,33048-54-3,330824-87-8,841275-14-7,330795-73-8 Supplier | KINGPHARM.GROUP
CMO CDMO service. KINGPHARM.GROUP supply 330645-26-6,33048-52-1,33048-54-3,330824-87-8,841275-14-7,330795-73-8 and related compounds.
841275-14-7
330645-26-6
33048-52-1
330824-87-8
33048-54-3
330795-73-8